Skip to main content

Find Clinical Trials

Home
Conditions
Demyelinating Diseases

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,931 public trials 462 recruiting studies

Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe

NCT00915577

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

Open-Label Safety Extension Study of Avonex

NCT00915460

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers

NCT00913666

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers

NCT00913250

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

Motor Imagery Practice in Neurological Rehabilitation

NCT00618085

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +15 more
Locations: Oxford Centre for Enablement Oxford, United Kingdom

View Trial Details

Completed

Differential Immune Effects of Natalizumab

NCT00859482

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Not specified

View Trial Details

Completed

Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity

NCT00358293

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +12 more
Locations: Tel Aviv Sourasky Medical Center- Neurology Department Tel Aviv, Israel

View Trial Details

Completed

Eszopiclone for Improving Sleep in Multiple Sclerosis (MS)

NCT00594087

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +14 more
Locations: University of Vermont Burlington, Vermont, United States

View Trial Details

Completed

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

NCT00099502

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Birmingham, Alabama, United States

Cullman, Alabama, United States

Phoenix, Arizona, United States

Tucson, Arizona, United States

View all 199 locations

View Trial Details

Completed

Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study

NCT00343590

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Logan College of Chiropractic Chesterfield, Missouri, United States

Logan College of Chirpractic Chesterfield, Missouri, United States

View Trial Details